GlassScriptPhysician profile
Howard J Stanton
NPI 1508978875
$2,971.92
in general payments reported to CMS, 2019-2025
18 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $887 · 2020: $494 · 2021: $278 · 2022: $510 · 2023: $307 · 2024: $300 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.21 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $914.23 | 2019-2023 | |
| Abbott Laboratories | $356.89 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $277.87 | 2019-2023 | Camzyos |
| Kestra Medical Technology Services, INC. | $251.53 | 2022-2025 | Assure Wcd |
| Boston Scientific Corporation | $228.93 | 2019-2025 | Wolverine Coronary Cutting Balloon, General - Balloon Catheters, Watchman Access System |
| Abiomed | $205.80 | 2023-2024 | Impella |
| Astellas Pharma US INC | $195.64 | 2019-2022 | |
| Amgen INC. | $133.75 | 2019-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.74 | 2020-2025 | Lifevest |
| Medtronic Vascular, INC. | $67.58 | 2020 | |
| Alnylam Pharmaceuticals INC. | $55.97 | 2021-2022 | |
| Pfizer INC. | $36.12 | 2020-2022 | |
| Novo Nordisk INC | $32.27 | 2023 | Ozempic |
| Janssen Pharmaceuticals, INC | $30.69 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $30.22 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $25.66 | 2019 | |
| Cardiovascular Systems INC. | $13.06 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Stanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.